X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10405) 10405
Publication (618) 618
Newsletter (101) 101
Book Review (74) 74
Book Chapter (36) 36
Magazine Article (22) 22
Newspaper Article (17) 17
Conference Proceeding (14) 14
Dissertation (9) 9
Book / eBook (4) 4
Transcript (4) 4
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (6048) 6048
humans (5615) 5615
animals (4191) 4191
index medicus (3801) 3801
female (3787) 3787
creatine (3082) 3082
creatine kinase - blood (2917) 2917
creatine kinase (2437) 2437
middle aged (2269) 2269
rats (2248) 2248
adult (2230) 2230
aged (1631) 1631
creatine kinase - metabolism (1185) 1185
cardiac & cardiovascular systems (1137) 1137
time factors (1066) 1066
pharmacology & pharmacy (1047) 1047
oxidative stress (931) 931
mice (902) 902
dietary supplements (880) 880
rats, wistar (848) 848
metabolism (823) 823
analysis (799) 799
neurosciences (780) 780
exercise (771) 771
physiological aspects (746) 746
treatment outcome (742) 742
heart (700) 700
research (694) 694
myocardium - metabolism (686) 686
creatine - metabolism (678) 678
health aspects (664) 664
rats, sprague-dawley (655) 655
biomarkers - blood (646) 646
physiology (633) 633
biochemistry & molecular biology (632) 632
electrocardiography (630) 630
creatine - administration & dosage (628) 628
skeletal-muscle (627) 627
sport sciences (615) 615
myocardium - pathology (611) 611
adolescent (607) 607
ischemia (606) 606
disease models, animal (599) 599
double-blind method (595) 595
dose-response relationship, drug (594) 594
enzymes (578) 578
l-lactate dehydrogenase - blood (569) 569
isoenzymes (559) 559
brain (550) 550
rodents (536) 536
surgery (529) 529
care and treatment (514) 514
magnetic resonance spectroscopy (503) 503
muscle, skeletal - drug effects (503) 503
prospective studies (494) 494
risk factors (492) 492
antioxidants (483) 483
muscle, skeletal - metabolism (482) 482
toxicology (479) 479
creatine-kinase (474) 474
heart - drug effects (463) 463
cardiology (458) 458
aspartate aminotransferases - blood (453) 453
creatine - blood (452) 452
medicine, research & experimental (452) 452
apoptosis (443) 443
myocardial infarction - drug therapy (441) 441
young adult (440) 440
cell biology (435) 435
proteins (432) 432
clinical neurology (426) 426
creatine kinase, mb form - blood (426) 426
administration, oral (424) 424
inflammation (406) 406
expression (401) 401
research article (401) 401
medicine (395) 395
nutrition & dietetics (394) 394
medicine & public health (392) 392
myocardium - enzymology (392) 392
supplementation (391) 391
injury (390) 390
kinases (386) 386
muscles (376) 376
myocardial infarction (373) 373
oxidative stress - drug effects (362) 362
reperfusion (361) 361
studies (361) 361
metabolites (357) 357
disease (354) 354
performance (346) 346
child (344) 344
mortality (340) 340
therapy (339) 339
biomarkers (338) 338
endocrinology & metabolism (335) 335
diagnosis (331) 331
aged, 80 and over (329) 329
muscle (329) 329
creatine - pharmacology (326) 326
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10225) 10225
Japanese (120) 120
German (83) 83
Russian (66) 66
Chinese (51) 51
French (43) 43
Italian (26) 26
Spanish (26) 26
Portuguese (18) 18
Polish (12) 12
Korean (10) 10
Danish (7) 7
Ukrainian (7) 7
Turkish (4) 4
Czech (3) 3
Swedish (3) 3
Arabic (2) 2
Bulgarian (2) 2
Dutch (2) 2
Hungarian (2) 2
Hebrew (1) 1
Indonesian (1) 1
Persian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 04/2011, Volume 364, Issue 16, pp. 1513 - 1522
Journal Article
The American Journal of Cardiology, ISSN 0002-9149, 2004, Volume 94, Issue 9, pp. 1140 - 1146
Three-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors (statins) are first-line treatments for hypercholesterolemia. Although exceedingly well... 
CLARITHROMYCIN | INDUCED RHABDOMYOLYSIS | LOVASTATIN | CARDIAC & CARDIOVASCULAR SYSTEMS | CONCOMITANT USE | ERYTHROMYCIN | FATAL RHABDOMYOLYSIS | ITRACONAZOLE | ROSUVASTATIN | DRUG-INTERACTION | CYCLOSPORINE | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Pyrroles - pharmacokinetics | Cytochrome P-450 Enzyme Inhibitors | Cytochrome P-450 Enzyme System - administration & dosage | Area Under Curve | Heptanoic Acids - pharmacokinetics | Humans | Middle Aged | Mibefradil - pharmacokinetics | Male | Protein Synthesis Inhibitors - administration & dosage | Verapamil - administration & dosage | Dose-Response Relationship, Drug | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics | Antiprotozoal Agents - pharmacokinetics | Drug Interactions | Itraconazole - pharmacokinetics | Pyrroles - administration & dosage | Clarithromycin - pharmacokinetics | Mibefradil - administration & dosage | Clarithromycin - administration & dosage | Heptanoic Acids - administration & dosage | Adult | Female | Itraconazole - administration & dosage | Drug Therapy, Combination | Double-Blind Method | Simvastatin - administration & dosage | Verapamil - pharmacokinetics | Biomarkers - blood | Simvastatin - pharmacokinetics | Protein Synthesis Inhibitors - pharmacokinetics | Atorvastatin Calcium | Anticholesteremic Agents - pharmacokinetics | Pravastatin - administration & dosage | Anticholesteremic Agents - administration & dosage | Adolescent | Antiprotozoal Agents - administration & dosage | Calcium Channel Blockers - administration & dosage | Creatine Kinase - drug effects | Calcium Channel Blockers - pharmacokinetics | Pravastatin - pharmacokinetics
Journal Article
Journal Article
Neuromodulation: Technology at the Neural Interface, ISSN 1094-7159, 11/2013, Volume 16, Issue 6, pp. 576 - 582
Journal Article
Journal Article
The Lancet Oncology, ISSN 1470-2045, 05/2018, Volume 19, Issue 5, pp. 603 - 615
Journal Article
Journal of Thoracic and Cardiovascular Surgery, The, ISSN 0022-5223, 2012, Volume 144, Issue 5, pp. 1241 - 1248
Background We previously performed a trial of intravenous landiolol hydrochloride during and after cardiac surgery (the PASCAL trial) and demonstrated a... 
Cardiothoracic Surgery | MORTALITY | SURGERY | PROPHYLAXIS | IMPACT | CARDIAC & CARDIOVASCULAR SYSTEMS | RESPIRATORY SYSTEM | HEART-FAILURE | ACTING BETA-BLOCKER | ORAL AMIODARONE | Single-Blind Method | Humans | Middle Aged | Male | Atrial Fibrillation - physiopathology | Arginine - analogs & derivatives | Troponin I - blood | C-Reactive Protein - metabolism | Coronary Artery Bypass - mortality | Time Factors | Atrial Fibrillation - mortality | Urea - analogs & derivatives | Fatty Acid-Binding Proteins - blood | Aged, 80 and over | Anti-Inflammatory Agents - administration & dosage | Female | Adrenergic beta-Antagonists - administration & dosage | Natriuretic Peptide, Brain - blood | Urea - administration & dosage | Drug Administration Schedule | Administration, Oral | Japan | Morpholines - administration & dosage | Treatment Outcome | Biomarkers - blood | Anti-Arrhythmia Agents - administration & dosage | Bisoprolol - administration & dosage | Atrial Fibrillation - blood | Coronary Artery Bypass - adverse effects | Pilot Projects | Fatty Acid Binding Protein 3 | Arginine - blood | Antioxidants - administration & dosage | Atrial Fibrillation - etiology | Creatine Kinase, MB Form - blood | Aged | Hemodynamics - drug effects | Serum Amyloid P-Component - metabolism | Infusions, Intravenous | Atrial Fibrillation - prevention & control | Prevention | Medical colleges | Bisoprolol | Atrial fibrillation | Surgery
Journal Article
Critical Reviews in Food Science and Nutrition, ISSN 1040-8398, 07/2019, Volume 59, Issue 13, pp. 2052 - 2060
According to the Academy of Nutrition and Dietetics' influential position statement on vegetarianism, meat and seafood can be replaced with milk, soy/legumes,... 
veganism in children | cognitive development | growth | phytoestrogens in pregnancy | Vegetarianism in children | birth ratio | GLYCEMIC-LOAD DIET | NEONATAL EXPOSURE | VITAMIN-B-12 DEFICIENCY | FOOD SCIENCE & TECHNOLOGY | CREATINE SUPPLEMENTATION | NUTRITION & DIETETICS | POLYUNSATURATED FATTY-ACID | IRON STATUS | SEX-RATIO | ACNE-VULGARIS | INSULINEMIC RESPONSES | AUSTRALIAN VEGETARIAN | Iron - administration & dosage | Zinc - administration & dosage | Soybeans | Taurine - deficiency | United States | Humans | Fetus - metabolism | Child, Preschool | Infant | United States Department of Agriculture | Mental Health | Eggs | Brain - metabolism | Fatty Acids, Omega-6 - administration & dosage | Diet, Vegetarian | Fatty Acids, Omega-3 - deficiency | Iron - deficiency | Creatine - administration & dosage | Creatine - deficiency | Female | Child Development - drug effects | Nutritional Status | Child Health | Fatty Acids, Omega-6 - deficiency | Phytoestrogens - administration & dosage | Child | Fatty Acids, Omega-3 - administration & dosage | Dietetics | Nutritional Requirements | Vitamin B 12 - administration & dosage | Child Nutritional Physiological Phenomena - drug effects | Fetal Development - drug effects | Vitamin B 12 Deficiency | Pregnancy | Taurine - administration & dosage | Dietary Supplements | Zinc - deficiency | Legumes | Brain | Nutrition | Fetuses | Dietary supplements | Seafood | Iron | Zinc | Vegetarianism | Meat | Government agencies | Veganism | Supplementation | Children
Journal Article
Trials, ISSN 1745-6215, 01/2019, Volume 20, Issue 1, pp. 34 - 11
BackgroundMajor depressive disorder (MDD) is a common psychiatric disorder. With systematic antidepressant treatment, 50-75% of patients have a treatment... 
Phosphocreatine | Fluoxetine | Randomized controlled trial | Adenosine triphosphate | Fast-acting antidepressant | Major depressive disorder | MEDICINE, RESEARCH & EXPERIMENTAL | CREATINE MONOHYDRATE AUGMENTATION | ENERGY | EFFICACY | SERTRALINE | PREFRONTAL CORTEX | DAMAGE | WOMEN | METABOLISM | HYPOTHESIS | COENZYME-Q10 | Adenosine Triphosphate - administration & dosage | Antidepressive Agents, Second-Generation - adverse effects | Humans | Middle Aged | Male | Antidepressive Agents, Second-Generation - administration & dosage | Feasibility Studies | Young Adult | Time Factors | China | Adult | Female | Drug Therapy, Combination | Fluoxetine - adverse effects | Adenosine Triphosphate - adverse effects | Depressive Disorder, Major - drug therapy | Affect - drug effects | Patient Health Questionnaire | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Serotonin Uptake Inhibitors - adverse effects | Treatment Outcome | Phosphocreatine - adverse effects | Phosphocreatine - administration & dosage | Randomized Controlled Trials as Topic | Depressive Disorder, Major - psychology | Administration, Intravenous | Pilot Projects | Serotonin Uptake Inhibitors - administration & dosage | Adolescent | Fluoxetine - administration & dosage | Aged | Depressive Disorder, Major - diagnosis | Usage | Physiological aspects | Dosage and administration | Drug therapy, Combination | Drug therapy | Health aspects | Testing
Journal Article
European Journal of Cancer, ISSN 0959-8049, 11/2017, Volume 86, pp. 334 - 348
Journal Article